Kinase inhibitors for CNS diseases: an analysis of the recent patent literature
{{output}}
Protein kinases (PKs), as members of an important target class in current pharmaceutical research, have been mostly exploited so far in therapeutic areas such as oncology and inflammation. However, basic research on some PKs as key components of molecular mech... ...